Journal of Drugs in Dermatology

View more issues:

Articles in July-August, 2005 issue of Journal of Drugs in Dermatology

• Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study
  by Aditya K. Gupta
• DNA repair lotion dimericine awaiting FDA approval
• Utilization of narrow band ultraviolet B light therapy and etanercept for the treatment of psoriasis
• ZD1839 for recurrent or metastatic SCC of the skin
• Characterizing serum protein patterns in selected skin diseases
• The research registry for neonatal lupus
• Cutaneous small vessel vasculitis due to famciclovir therapy
  by Syed O. Ali
• A review of the chemopreventive and chemotherapeutic effects of topical and oral retinoids for both cutaneous and internal neoplasms
  by Pooja Khera
• Blood pressure levels decrease during Mohs micrographic surgery
  by J. Alcalay
• Acne fulminans in Marfan syndrome
  by Uwe Wollina
• Aczone and acne
• FDA approves chlorhexidine gluconate 2% cloth
• New histopathological classification of actinic keratosis
  by Clay J. Cockerell
• Mitozantrone-induced onycholysis associated with subungual abscesses, paronychia, and pyogenic granuloma
  by Anatoli Freiman
• Laser News
  by Macrene Alexiades-Armenakas
• Restylane gel
• Serrano SA ends clinical trials for onercept and canvaxin
• Infliximab to treat dermatomyositis and polymyositis
• Treatment of female pattern hair loss with oral antiandrogens
• Skin response to sunlight
• To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• New technologies for in vivo diagnoses of early melanoma
  by Ashfaq A. Marghoob
• Celecoxib in preventing skin cancer
• Topical anesthetics for cosmetic and laser dermatology
  by Snehal P. Amin
• Study of psoriatic arthritis
• Cause and natural course of pediatric-onset mastocytosis
• Community acquired staphylococcus aureus infections: is vaccination the answer?
• Herpes zoster vaccine
• The effects of microdermabrasion on skin remodeling
• A double-blinded, placebo-controlled study of Botox® for the treatment of subjects with chin rhytids
  by Kenneth Beer
• Tetracycline in preventing skin rash in patients who are receiving drugs such as gefitinib and cetuximab for cancer
• Conditioning, the placebo effect, and psoriasis
• Brown recluse spider envenomation: dermatologic application of hyperbaric oxygen therapy
  by William D. Tutrone
• Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals
• OTC topical steroids for psoriasis
• Phase II trials of HPV vaccine look promising
• To study the effects of CD25 and low dose Cyclosporin in the treatment of active psoriasis vulgaris
• Treatment of nevirapine-associated DRESS syndrome with intravenous immune globulin
  by Katherine S. Fields
• Etanercept for treatment of hidradenitis
• A letter from the editor
  by Susan Weinkle
• Suicidal ideation in the dermatology clinic
  by Chad A. Brown
• The acquisition of blood and skin samples from normal volunteers to support research activities on dermatologic diseases
• Genetic analysis of familial keloids
• Alopecia areata registry
• The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs
  by Craig G. Burkhart
• Verapamil-induced subacute cutaneous lupus erythematosus
  by Boaz Kurtis
• Cell infusions and interleukin-2 to treat metastatic melanoma
• Monoclonal antibody treatment for systemic lupus erythematosus
• Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%
• Fraxel Laser approved for skin resurfacing
• Comparison of telavancin and vancomycin for complicated skin and skin structure infections with a focus on methicillin-resistant staphylococcus aureus
• Bioengineered skin and wound healing
• Oral acyclovir for neonatal HSV disease of the skin, eyes, and mouth
• Comparison of intense pulsed light to 595-nm long-pulsed pulsed dye laser for treatment of hypertrophic surgical scars: a pilot study
  by Supriya G. Bellew
• Topical metronidazole combination therapy in the clinical management of rosacea
  by James Q. Del Rosso
• Clarinex-D 24 Hour extended release tablets approved by the FDA
• Skin Incision Study
• Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study
• Copper histidine therapy for Menkes diseases
• Flaps & grafts workshop
• Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis
• Leptin to treat lipodystrophy
• Preliminary testing of new treatment for chronic leg wounds